Olon Group completes acquisition of Huvepharma Italia Srl to strengthen its global market presence

Sep 04, 2024•11 months ago

Acquiring Company

Olon Group

Acquired Company

Huvepharma Italia Srl

Milan

GaressioPharmaceuticalBiotechnologyManufacturing

Description

Olon Group, a global pharmaceutical player, has successfully acquired Huvepharma Italia Srl. This strategic acquisition aims to expand Olon's production potential, enhance its product offering, and strengthen its position in the global market for active pharmaceutical ingredients (APIs).

Company Information

Company

Olon Group

Location

Milan, Lombardy, Italy

About

Olon Group is a global pharmaceutical company that focuses on growth, consolidation, and global market expansion through internal development and strategic acquisitions. With over four decades of experience, Olon Group is committed to advancing innovative and high-tech offerings to customers in the pharmaceutical industry.

Related People

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed